Learning Objectives:

1. Review clinicopathologic features of triple negative breast cancer

2. Discuss updates in treatment of early stage triple negative breast cancer

3. Understand changing landscape or novel therapeutics in advanced triple negative breast cancer

Session date: 
11/07/2022 - 8:30am to 9:30am CST
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Poornima Saha